Research
Hormonal
Participants using the program plus medication were more likely to achieve clinically significant weight loss, with odds ratios ranging from 1.46 to 2.57 for ≥5% weight loss across timepoints.
Integrating a behavioral support app with GLP-1 RA treatment can significantly enhance weight loss outcomes.
StrongSupportsmedium confidence
Participants using the program plus medication were more likely to achieve clinically significant weight loss, with odds ratios ranging from 1.46 to 2.57 for ≥5% weight loss across timepoints (P< .001).
Why this rating
Based on a retrospective observational cohort study with a large sample size.
Source
Digital augmentation of glucagon-like peptide-1 (GLP-1) for obesity management: A retrospective study (Preprint)
Belinda Davey et al. · 2026
cohort · n=6753
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →